Then, the expression of the replicative senescence marker CD57 was used to identify bona fide senescent T cells, which accounted to 30% of THD cells in healthy age‐matched donors, and about 10% in NSCLC patients (Fig EV4C). This evidence concerns the gene B3GAT1 and non-small cell lung carcinoma.